ONWD — Onward Medical NV Income Statement
0.000.00%
Last trade - 00:00- €181.19m
- €126.74m
- €3.78m
Annual income statement for Onward Medical NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.104 | 0.068 | 0.229 | 3.78 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | 0.207 | 2.74 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 28.5 | 32.1 | 35.5 | 35.1 | 44.7 |
| Operating Profit | -28.5 | -32 | -35.5 | -34.9 | -40.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -34.2 | -33.5 | -36.1 | -35.8 | -41.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -34.3 | -32.8 | -36.2 | -35.7 | -41.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -34.3 | -32.8 | -36.2 | -35.7 | -41.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -34.3 | -32.8 | -36.2 | -35.7 | -41.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.62 | -1.09 | -1.2 | -0.8 | -0.895 |